Equinox Gold: Canaccord Reiterates Buy Rating, $12 Price Target

Early this month, Equinox Gold Corp. (TSX: EQX) reported its third quarter financial results. The company announced revenues of $245.1 million, slightly higher than the $244.5 million last year. Gross margins from mining were $49.2 million, adjusted EBITDA was $62 million, while earnings per share came in at -$0.02. The company produced 139,758 ounces of gold while selling 137.144 ounces for the quarter. The average selling gold price was $1,780 while the all-in sustaining price was $1,327.

Equinox Gold currently has 12 analysts covering the stock with an average 1-month price target of C$14.71. Out of the 12 analysts, 1 analyst has a strong buy rating, 9 have buys and 2 analysts have hold ratings. The street high comes from Stifel-GMP and sits at C$20 while the lowest price target is C$10.50.

In Canaccord Genuity’s earnings review, they reiterated their C$12 price target and buy rating, writing, “We continue to like the company for its unrivaled growth trajectory and leverage to gold prices,” but warn that their forecasts expect Equinox to be free cash flow negative into 2023. This could potentially make Equinox’s share price underperform due to a lack of liquidity while in growth mode.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

For the quarter, Canaccord says that the majority of their operating results came in line with their estimates except general, administrative, and corporate costs came in higher than expectations. Adjusted EBITDA also came in 30% lower than Canaccord’s $88.5 million estimate. For gold production per mine, the majority either came in-line or slightly beat except for the Mesquite and Mercedes mine which came in 20% and 13% lower than their estimates.

Canaccord believes that management reiterating their full-year guidance is setting up the fourth quarter to be a strong quarter. They believe that the company will produce 212,000 ounces of gold, a 52% increase for the fourth quarter. They expect this will be able to happen thanks to Mesquite and Los Filos production increase.

They say that Equinox’s cash position of $300 million will be able to fund its growth projects but warn that their balance sheet could potentially come under pressure if they don’t find additional sources of liquidity should the average selling price drops below $1,700.

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Everybody Should Own Gold | George Bee – U.S. Gold Corp.

A $40M Company Created $2B in Mining Value | John-Mark Staude – Riverside Resources

The Debt Crisis Is Turning Gold Into Money | Shawn Khunkhun – Contango Silver and Gold

Recommended

First Majestic Produces 3.4 Million Ounces of Silver in Q3 2026, Jerritt Canyon Restart Remains on Track

Altamira Gold Drills 134 Metres of 0.5 g/t Gold at Maria Bonita, Hole Ends in Mineralization

Related News

BMO Cuts Roger Communications’ Price Target After Boardroom Drama Flares Up

On October 8th, The Globe and Mail reported on the recent and abrupt departure of...

Sunday, October 17, 2021, 01:07:00 PM

Canopy Growth Sees Consensus Estimates Point To Q1 2023 Revenues Of C$113 Million

Canopy Growth (TSX: WEED will be reporting its fiscal first quarter financial results tomorrow before...

Thursday, August 4, 2022, 11:38:00 AM

Aurora Cannabis: Seven Analysts Slash Price Targets In Wake Of Blowout Fourth Quarter

Earlier this week, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported their fourth-quarter financials, after having...

Thursday, September 24, 2020, 11:33:00 AM

CloudMD: Canaccord Lowers Revenue Estimates, Maintains Ratings

On May 28th, CloudMD Software & Services Inc. (TSXV: DOC) reported its first-quarter financial results....

Monday, May 31, 2021, 10:31:00 AM

Teladoc Health: Numerous Analysts Raise Price Targets Following Q3 Earnings

Yesterday, Teladoc Health (NYSE: TDOC) reported its third quarter earnings results, reporting $228.8 million in...

Saturday, October 31, 2020, 02:02:00 PM